Vaccines

Jul 24, 2017
By Pharmaceutical Technology Editors
GE Healthcare partners with Oritain for an independent test that can confirm the country of origin of fetal bovine serum (FBS), a component of biopharmaceutical production.
Jul 17, 2017
By Pharmaceutical Technology Editors
GSK plans to deliver up to 40 million doses of its quadrivalent flu vaccine for the 2017–2018 season.
Jul 11, 2017
By Pharmaceutical Technology Editors
The acquisition will add recombinant-based influenza vaccine to Sanofi Pasteur’s portfolio
Jun 28, 2017
By Pharmaceutical Technology Editors
Two recently-signed agreements will transfer Takeda’s measles and acellular pertussis vaccine technologies to India-based multinational company Biological E. Limited to develop low-cost combination vaccines including diphtheria, tetanus and acellular pertussis (DTaP), and measles-rubella (MR) vaccines.
Jun 28, 2017
By Pharmaceutical Technology Editors
The directorate highlights its 2016 achievements.
Jun 22, 2017
By Pharmaceutical Technology Editors
A loan from the European Investment Bank will give BiondVax resources for Phase III trials and a manufacturing facility for its universal flu vaccine.
Apr 12, 2017
By Pharmaceutical Technology Editors
The agency issued its recommendation for the influenza virus strains European vaccine manufacturers should include for 2017.
Apr 11, 2017
By Pharmaceutical Technology Editors
In a new study, researchers from Boston Children’s Hospital study responses to pneumococcal vaccine in infant monkeys.
Jan 09, 2017
The partnership will focus on providing practical information to clients on the development of biologics and vaccines.
Dec 16, 2016
By Pharmaceutical Technology Editors
Univercells received a grant from the Bill & Melinda Gates Foundation for the development of a vaccine manufacturing platform.
native1_300x100
lorem ipsum